Viscontour® Serum Med in Hydration of Facial Skin

TRB Chemedica

Status: Completed

Conditions: Sodium Hyaluronate

Treatments: Device: Viscontour® Serum Med

Study type: Observational

Funder types: Industry

Identifiers

NCT03494140

VISCH-PMCF-DE-2016-09

Details and patient eligibility

About

The objective of this study is to confirm the clinical safety and efficacy of Viscontour® Serum Med in the hydration of facial tissue.

Enrollment: 40 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Females ≥ 18 years of age and in good general health condition
2. Signed informed consent
3. Existing Viscontour® Serum Med recommendation (i.a. for hydration, soothing, nourishing and refreshing the complexion and for use in combination with a day cream)

Exclusion criteria

1. Known hypersensitivity to one of the Viscontour® Serum Med components
2. Known pregnancy or lactating females
3. Subjects not capable of contracting and of understanding the nature, risks, significance and implications of the clinical investigation and unable to form a rational intention in the light of these facts
4. Subjects unable to understand informed consent or having a high probability of non compliance to the study procedures and / or non completion of the study according to investigator's judgement (e.g. illiteracy, insufficient knowledge of local language)